Skip to main content
. 2020 Jun 2;7(3):269–277. doi: 10.3233/JND-190464

Fig. 1.

Fig. 1

MG-ADL total scores before and during 12 months’ treatment with eculizumab. MG-ADL, Myasthenia Gravis–Activities of Daily Living.